238 related articles for article (PubMed ID: 34872276)
1. A systematic review and meta-analysis of the gut microbiota-dependent metabolite trimethylamine N-oxide with the incidence of atrial fibrillation.
Yang WT; Yang R; Zhao Q; Li XD; Wang YT
Ann Palliat Med; 2021 Nov; 10(11):11512-11523. PubMed ID: 34872276
[TBL] [Abstract][Full Text] [Related]
2. Gut microbe-generated metabolite trimethylamine N-oxide and the risk of diabetes: A systematic review and dose-response meta-analysis.
Zhuang R; Ge X; Han L; Yu P; Gong X; Meng Q; Zhang Y; Fan H; Zheng L; Liu Z; Zhou X
Obes Rev; 2019 Jun; 20(6):883-894. PubMed ID: 30868721
[TBL] [Abstract][Full Text] [Related]
3. Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis.
Schiattarella GG; Sannino A; Toscano E; Giugliano G; Gargiulo G; Franzone A; Trimarco B; Esposito G; Perrino C
Eur Heart J; 2017 Oct; 38(39):2948-2956. PubMed ID: 29020409
[TBL] [Abstract][Full Text] [Related]
4. The Gut Microbial Metabolite Trimethylamine N-Oxide and Hypertension Risk: A Systematic Review and Dose-Response Meta-analysis.
Ge X; Zheng L; Zhuang R; Yu P; Xu Z; Liu G; Xi X; Zhou X; Fan H
Adv Nutr; 2020 Jan; 11(1):66-76. PubMed ID: 31269204
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota-derived metabolite trimethylamine N-oxide (TMAO) potentially increases the risk of obesity in adults: An exploratory systematic review and dose-response meta- analysis.
Dehghan P; Farhangi MA; Nikniaz L; Nikniaz Z; Asghari-Jafarabadi M
Obes Rev; 2020 May; 21(5):e12993. PubMed ID: 32017391
[TBL] [Abstract][Full Text] [Related]
6. Novel findings of the association between gut microbiota-derived metabolite trimethylamine
Farhangi MA; Vajdi M
Crit Rev Food Sci Nutr; 2020; 60(16):2801-2823. PubMed ID: 32462890
[TBL] [Abstract][Full Text] [Related]
7. The Gut Microbial-Derived Metabolite Trimethylamine N-Oxide and Atrial Fibrillation: Relationships, Mechanisms, and Therapeutic Strategies.
Huang R; Yan L; Lei Y
Clin Interv Aging; 2021; 16():1975-1986. PubMed ID: 34876810
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota-associated metabolite trimethylamine N-Oxide and the risk of stroke: a systematic review and dose-response meta-analysis.
Farhangi MA; Vajdi M; Asghari-Jafarabadi M
Nutr J; 2020 Jul; 19(1):76. PubMed ID: 32731904
[TBL] [Abstract][Full Text] [Related]
9. Significant correlation between the gut microbiota-derived metabolite trimethylamine-N-oxide and the risk of stroke: evidence based on 23 observational studies.
Zhang H; Yao G
Eur J Clin Nutr; 2023 Jul; 77(7):731-740. PubMed ID: 35468932
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota-associated trimethylamine N-oxide and increased cardiometabolic risk in adults: a systematic review and dose-response meta-analysis.
Abbasalizad Farhangi M; Vajdi M
Nutr Rev; 2021 Aug; 79(9):1022-1042. PubMed ID: 33270896
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiota-dependent trimethylamine N-oxide and all-cause mortality: Findings from an updated systematic review and meta-analysis.
Farhangi MA
Nutrition; 2020 Oct; 78():110856. PubMed ID: 32592979
[TBL] [Abstract][Full Text] [Related]
12. A potential relationship between gut microbes and atrial fibrillation: Trimethylamine N-oxide, a gut microbe-derived metabolite, facilitates the progression of atrial fibrillation.
Yu L; Meng G; Huang B; Zhou X; Stavrakis S; Wang M; Li X; Zhou L; Wang Y; Wang M; Wang Z; Deng J; Po SS; Jiang H
Int J Cardiol; 2018 Mar; 255():92-98. PubMed ID: 29425570
[TBL] [Abstract][Full Text] [Related]
13. Gut Microbial Metabolite Trimethylamine N-Oxide Is Related to Thrombus Formation in Atrial Fibrillation Patients.
Gong D; Zhang L; Zhang Y; Wang F; Zhao Z; Zhou X
Am J Med Sci; 2019 Dec; 358(6):422-428. PubMed ID: 31666184
[TBL] [Abstract][Full Text] [Related]
14. Metagenomic data-mining reveals enrichment of trimethylamine-N-oxide synthesis in gut microbiome in atrial fibrillation patients.
Zuo K; Liu X; Wang P; Jiao J; Han C; Liu Z; Yin X; Li J; Yang X
BMC Genomics; 2020 Jul; 21(1):526. PubMed ID: 32731896
[TBL] [Abstract][Full Text] [Related]
15. Relationship between trimethylamine N-oxide and the risk of hypertension in patients with cardiovascular disease: A meta-analysis and dose-response relationship analysis.
Han JM; Guo L; Chen XH; Xie Q; Song XY; Ma YL
Medicine (Baltimore); 2024 Jan; 103(1):e36784. PubMed ID: 38181288
[TBL] [Abstract][Full Text] [Related]
16. Gut Microbiota-Derived Trimethylamine N-Oxide and Kidney Function: A Systematic Review and Meta-Analysis.
Zeng Y; Guo M; Fang X; Teng F; Tan X; Li X; Wang M; Long Y; Xu Y
Adv Nutr; 2021 Jul; 12(4):1286-1304. PubMed ID: 33751019
[TBL] [Abstract][Full Text] [Related]
17. Plasmatic trimethylamine N-oxide and its relation to stroke: A systematic review and dose-response meta-analysis.
Chen P; Guo Z
Medicine (Baltimore); 2022 Jul; 101(29):e29512. PubMed ID: 35866835
[TBL] [Abstract][Full Text] [Related]
18. Akkermansia muciniphila prevents cold-related atrial fibrillation in rats by modulation of TMAO induced cardiac pyroptosis.
Luo Y; Zhang Y; Han X; Yuan Y; Zhou Y; Gao Y; Yu H; Zhang J; Shi Y; Duan Y; Zhao X; Yan S; Hao H; Dai C; Zhao S; Shi J; Li W; Zhang S; Xu W; Fang N; Gong Y; Li Y
EBioMedicine; 2022 Aug; 82():104087. PubMed ID: 35797768
[TBL] [Abstract][Full Text] [Related]
19. Trimethylamine N-oxide as a risk marker for ischemic stroke in patients with atrial fibrillation.
Liang Z; Dong Z; Guo M; Shen Z; Yin D; Hu S; Hai X
J Biochem Mol Toxicol; 2019 Feb; 33(2):e22246. PubMed ID: 30370581
[TBL] [Abstract][Full Text] [Related]
20. Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta-Analysis of Prospective Studies.
Heianza Y; Ma W; Manson JE; Rexrode KM; Qi L
J Am Heart Assoc; 2017 Jun; 6(7):. PubMed ID: 28663251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
